XNAS: NKTR
Nektar Therapeutics Live Stock Price Today, Share Analysis and Chart
about
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company dir...
Read More
68.26
1.21
(1.80%)
538.4K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Nektar Therapeutics Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..